sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Spire Healthcare Stake
The Vanguard Group, Inc. has revealed its interest in Spire Healthcare Group plc through a Form 8.3 disclosure, in accordance with Rule 8.3 of the Takeover Code. This disclosure, dated 19 May 2026, details Vanguard's public opening position regarding relevant securities representing 1% or more in Spire Healthcare.
The form indicates that Vanguard owns and controls 14,438,704 ordinary 1p shares, representing a 3.58% stake in Spire Healthcare. On 18 May 2026, Vanguard executed trades involving the sale of 7,622 units of the 1p ordinary shares at prices of 2.22 GBP and 2.23 GBP per unit.
Notably, there are no cash-settled or stock-settled derivative positions disclosed, nor are there any rights to subscribe for new securities in this instance.
Vanguard reported no existing agreements, arrangements, or understandings concerning options or derivatives linked to voting rights or future securities transactions. This indicates a straightforward equity interest in the healthcare company.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.